Albany, NY -- (SBWIRE) -- 06/23/2015 -- Aptamers are single-stranded RNA or DNA molecules that can bind to pre-selected target molecules such as peptides and proteins with high specificity and resemblance. These molecules can take various shapes owing to their propensity to create helices and single-stranded loops, which explains their versatility in binding these diverse targets. These aptamers are utilized as sensors and therapeutic devices. They are also used to control the cellular procedures as well as guide drugs to their specified cellular targets. Differing to the original genetic material, their specifications and characteristics are not directly identified by their main sequences, but by their triennial structure.

Browse the full Aptamers Market Report @ :
http://www.transparencymarketresearch.com/aptamers-market.html

The global industry for aptamers is an emerging market, largely considered as a replacement to antibodies in the medical as well as the healthcare industry. It is likely to expand rapidly in varied application areas such as diagnostics and therapeutics. The aptamer technology is broadly applied in laboratory diagnosis, disease treatment, pharmaceutical studies, molecular recognition, and drug discovery. Additionally, these aptamers play a significant role in the production of better and cost-efficient medicines.

The global aptamers market is experiencing a rapid growth owing to the continuous efforts by major participants to develop new and innovative applications in the areas of therapeutics, diagnostics, and research using aptamer technology. In addition to this, the special features of aptamers such as high specificity, cost-effective production, and low immunogenic properties are expected to attract researchers to raise investments in the global aptamers market, thereby propelling the market growth. However, ethical issues and strict regulations associated with aptamers will restrict the growth of this market in future.

Browse the full Aptamers Market Press Release @ :
http://www.transparencymarketresearch.com/pressrelease/aptamers-market.htm

In 2012, the global aptamers industry had reached US$93.0 million. It is estimated that this market will be expanding at an impressive CAGR of 73.1% during the period of 2013 to 2019 and will reach US$4,333.0 million by the end of the forecast period.

Global Aptamers Industry: Asia Pacific to Become Fastest Developing Region

The aptamers market in North America held for the largest market share, which was more than 45% of the global aptamers industry in 2012. Europe held the second largest share of the overall market. Asia Pacific is likely to become the fastest developing region owing to the increasing initiatives started by the governments for the advancement of the aptamer technology loaded with enormous growth opportunities.

Based on types of aptamers, nucleic acid aptamers market was considered as the biggest market segment in 2012. This trend is expected to continue as this segment will retain its dominance, exhibiting the highest growth rate during the forecast period. The development in this segment is credited to increase in the usage of nucleic acid aptamers in diagnostic applications added with rise in the research and development activities.

Get Free Sample Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1335

On the basis of the application, the diagnostics market held the biggest market share in the global aptamers industry in 2012. The availability of several diagnostic kits produced by major players for in vitro diagnosis was the key driver for this market. However, the therapeutics market is likely to expand at the highest growth rate owing to the increase in the research and development activities to develop innovative therapeutic agents.

Global Aptamers Industry: Rise in Scientific Research Activities to Boost Market Growth

CD Genomics, Ophthotech Corporation, NOXXON Pharma AG, Aptamer Sciences, Inc., Aptagen, LLC, Neo Ventures Biotechnology, Inc., TriLink Biotechnologies, Inc., Bioapter S.L., Base Pair Biotechnologies, Inc., Vivonics, Inc., Aptamer group, Regado Biosciences, Inc., Optech Biotech, AM Biotechnologies, LLC, and Somalogic, Inc. are the major players participating in the market for aptamers across the globe.

The rise in scientific research activities regarding aptamer technology and increase in the participation of private firms for the development of aptamers is likely to boost the growth of this market, worldwide. Apart from this, the joint efforts of the major players to develop inventive aptamer technologies is expected to act as the key driving force behind the growth of this market.

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.